NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Press Enter or click the Search button to begin your search.

Back to Results
High Protein Intake Improves Insulin Sensitivity but Exacerbates Bone Resorption in Immobility (WISE Study)Inactivity, like bed rest (BR), causes insulin resistance (IR) and bone loss even in healthy subjects. High protein intake seems to mitigate this IR but might exacerbate bone loss. We hypothesized that high protein intake (animal:vegetable protein ratio: 60:40), isocaloric, compared to the control group plus high potassium intake would prevent IR without affecting bone turnover. After a 20-day ambulatory adaptation to controlled confinement and diet, 16 women participated in a 60-day, 6 deg head-down-tilt BR and were assigned randomly to one of the two groups. Control subjects (CON, n=8) received 1g/kg body mass/d dietary protein. Nutrition subjects (NUT, n=8) received 1.45g/kg body mass/d dietary protein plus 7.2g branched chain amino acids per day during BR. All subjects received 1670 kcal/d. Bed rest decreased glucose disposal by 35% (p<0.05) in CON. Isocaloric high protein intake prevented insulin resistance, but exacerbated bed rest induced increase in bone resorption markers C-telopeptide (> 30%) and Ntelopeptide (>20%) (both: p<0.001). Bone formation markers were unaffected by high protein intake. We conclude from these results that high protein intake might positively affect glucose tolerance, but might also foster bone loss. Further long-duration studies are mandatory before high protein intake for diabetic patients, who have an increased fracture risk, might be recommended.
Document ID
20110023091
Acquisition Source
Johnson Space Center
Document Type
Abstract
Authors
Heer, Martina
(Bonn Univ. Germany)
Smith, Scott M.
(NASA Johnson Space Center Houston, TX, United States)
Frings-Meuthen, Petra
(Deutsche Forschungsanstalt fuer Luft- und Raumfahrt Koln, Germany)
Zwart, Sara R.
(Universities Space Research Association Houston, TX, United States)
Baecker, Natalie
(Bonn Univ. Germany)
Date Acquired
August 25, 2013
Publication Date
April 21, 2012
Subject Category
Aerospace Medicine
Report/Patent Number
JSC-CN-25222
Report Number: JSC-CN-25222
Meeting Information
Meeting: 2012 Experimental Biology (EB 2012) Meeting
Location: San Diego, CA
Country: United States
Start Date: April 21, 2012
End Date: April 25, 2012
Distribution Limits
Public
Copyright
Public Use Permitted.
No Preview Available